Rigel Pharmaceuticals
Utility Patents

Last updated:

List of all Rigel Pharmaceuticals patents 55 in total

Status Patent
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Pyrazole compounds and methods for making and using the compounds External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: TGF-beta inhibitors External link
Filling date: 26 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Benzazole compounds and methods for making and using the compounds External link
Filling date: 26 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 22 Mar 2022
Grant
Utility: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds External link
Filling date: 26 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: Prodrugs of 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: Compounds and method for treating autoimmune diseases External link
Filling date: 26 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 16 Nov 2021
Grant
Utility: Direct AMPK activators External link
Filling date: 26 Sep 2025 Issue date: 16 Nov 2021
Grant
Utility: Fumarate analogs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Sep 2021
Grant
Utility: Tyrosine kinase inhibitors External link
Filling date: 26 Sep 2025 Issue date: 7 Sep 2021
Grant
Utility: ACVR2A-specific antibody and method of treatment of muscle atrophy External link
Filling date: 26 Sep 2025 Issue date: 31 Aug 2021
Grant
Utility: Kinase inhibitors and methods for making and using External link
Filling date: 26 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: TGF- inhibitors External link
Filling date: 26 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 18 May 2021
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 13 Apr 2021
Grant
Utility: Amide compounds and method for making and using External link
Filling date: 26 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: AMPK-activating heterocyclic compounds and methods for using the same External link
Filling date: 26 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: IRAK inhibitors and method for making and using External link
Filling date: 26 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: Prodrugs of Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 12 Jan 2021
Grant
Utility: 2,3-Disubstituted pyridine compounds as TGF-.beta. inhibitors and methods of use External link
Filling date: 26 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Tyrosine kinase inhibitors External link
Filling date: 26 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: TGF-.beta. inhibitorC External link
Filling date: 26 Sep 2025 Issue date: 3 Nov 2020
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Protein kinase C inhibitors and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Prodrugs of NRF2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Benzazole compounds and methods for making and using the compounds External link
Filling date: 26 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Antigen binding molecules to TIGIT External link
Filling date: 26 Sep 2025 Issue date: 1 Sep 2020
Grant
Utility: 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Fused imidazole derivatives as TGF-beta inhibitors External link
Filling date: 26 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Kinase inhibitors and methods for making and using External link
Filling date: 26 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Prodrugs of 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 11 Feb 2020
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 11 Feb 2020
Grant
Utility: Fumarate analogs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Tetrazolones as a carboxylic acid bioisosteres External link
Filling date: 26 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Tyrosine kinase inhibitors External link
Filling date: 26 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 24 Sep 2019

Showing 1 to 50 of 55 patents.